| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0192-0561(92)90041-I |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:019205619290041I?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:019205619290041I?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1624227 |
| P50 | author | Ellen Vitetta | Q4795310 |
| Jonathan W Uhr | Q106192665 | ||
| P2093 | author name string | J. Richardson | |
| A. M. Soler-Rodriguez | |||
| P2860 | cites work | A severe combined immunodeficiency mutation in the mouse | Q28274531 |
| Toxicity of abrin and ricin in mice and dogs | Q34661780 | ||
| THE HISTOLOGICAL CHANGES PRODUCED BY RICIN AND ABRIN INTOXICATIONS. | Q36227654 | ||
| Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins | Q36356510 | ||
| The biology of cachectin/TNF--a primary mediator of the host response | Q38269386 | ||
| Modification of the carbohydrate in ricin with metaperiodate and cyanoborohydride mixtures: effect on binding, uptake and toxicity to parenchymal and non-parenchymal cells of rat liver | Q38352020 | ||
| Assays for tumour necrosis factor and related cytokines | Q38601014 | ||
| Redesigning nature's poisons to create anti-tumor reagents | Q39682102 | ||
| Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor). | Q39839327 | ||
| The preparation and cytotoxic properties of antibody-toxin conjugates | Q40330042 | ||
| Ricin: The toxic protein of castor oil seeds | Q40905808 | ||
| Renal lesion in nude mice | Q40978070 | ||
| Comparison of in vitro cell cytotoxic assays for tumor necrosis factor | Q44180676 | ||
| A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome | Q45919524 | ||
| Statistics for Business and Economics | Q58272591 | ||
| Effect of mild charge modification of albumin on renal excretion in the rat | Q68046328 | ||
| Effect of chemical deglycosylation on the in vivo fate of ricin A-chain | Q68808837 | ||
| Vascular permeability factor, an endothelial cell mitogen related to PDGF | Q69116052 | ||
| Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution | Q70078986 | ||
| The preparation of deglycosylated ricin by recombination of glycosidase-treated A- and B-chains: effects of deglycosylation on toxicity and in vivo distribution | Q70319714 | ||
| Studies on the Toxic Action of Ricin | Q72843597 | ||
| THE ROLE OF ENDOTOXIN IN THE EXTRACELLULAR COAGULATION OF LIMULUS BLOOD | Q76956779 | ||
| Biochemical mechanisms and morphological selectivity in hepatotoxicity: studies in cultures of hepatic-parenchymal and non-parenchymal cells | Q93654492 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| immunology | Q101929 | ||
| P304 | page(s) | 281-291 | |
| P577 | publication date | 1992-02-01 | |
| P1433 | published in | International Journal of Immunopharmacology | Q24031590 |
| P1476 | title | The toxicity of chemically deglycosylated ricin A-chain in mice | |
| P478 | volume | 14 |
| Q36829224 | Anthrax toxin-mediated delivery of the Pseudomonas exotoxin A enzymatic domain to the cytosol of tumor cells via cleavable ubiquitin fusions |
| Q35878388 | Characterization of Ricin and R. communis Agglutinin Reference Materials |
| Q36455711 | Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome |
| Q73102077 | Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice |
| Q37029370 | Linked-in: design and efficacy of antibody drug conjugates in oncology |
| Q36301063 | N-glycosylation does not affect the catalytic activity of ricin a chain but stimulates cytotoxicity by promoting its transport out of the endoplasmic reticulum |
| Q41540554 | Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates |
| Q51496298 | Progress in biological threat agent vaccine development: a repeat-dose toxicity study of a recombinant ricin toxin A-chain (rRTA) 1-33/44-198 vaccine (RVEc) in male and female New Zealand white rabbits. |
| Q41959941 | Ricin induces the production of tumour necrosis factor-alpha and interleukin-1 beta by human peripheral-blood mononuclear cells |
| Q52553231 | Ricin toxin contains three lectin sites which contribute to its in vivo toxicity. |
| Q35866996 | The need for continued development of ricin countermeasures |
| Q41664945 | Vascular leak syndrome: a side effect of immunotherapy |
Search more.